Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
The
#cancer community is our inspiration to drive change. What is your inspiration to take action in the fight against cancer? Create your own#IAmAndIWill
pledge and share it with the world: https://bit.ly/2Ukvwwt
#OncologyInspired#WorldCancerDay
pic.twitter.com/LahFUSYDD3
-
At
#Bayer, we are inspired every day by the support in the#cancer community around the world. This#WorldCancerDay
, learn more about their stories and how we are driving change in cancer care: https://bit.ly/37J453t
#OncologyInspiredpic.twitter.com/tomdgK1jVt
-
Tomorrow is
#WorldCancerDay
. At #Bayer, we are sharing our#IAmAndIWill
pledges to show how we are inspired to take action against #cancer. What is your pledge? Create one yourself here: https://bit.ly/2Ukvwwt#OncologyInspiredpic.twitter.com/p3L37jttWs
-
#DYK neglected tropical diseases still threaten the lives of around 1.5 billion people worldwide?@Bayer is proud to be part of#WorldNTDDay and is committed to#beatNTDspic.twitter.com/q2ap6tBAft
-
As
#JPM20 comes to a close, we’re reflecting on an exciting week. Great to share information on our updated#partnering approach & looking forward to building the momentum of collaboration throughout 2020 and beyond to benefit patients around the world#CollaborateToCure#JPM2020pic.twitter.com/Ux55CVDR5m
-
”At Leaps we also consider venture investment to be a marathon, not a sprint. We strongly believe in 4-6 years as an investment horizon to advance true breakthroughs rather than quick wins“, said Juergen Eckhardt, Head of
@LeapsByBayer#daretoleap#BiotechShowcase#JPM2020#JPM20pic.twitter.com/lvcey0Ci54
-
#CollaborateToCure: Read the story of research scientist Steven Ferrara from our partner@broadinstitute on how joining forces through#collaboration can make a change for#patients. Full interview here: https://bit.ly/2QSrdX9#JPM20#JPM2020pic.twitter.com/Bgvfru4Gpx
-
Live from
#JPM20:#Bayer‘s pharmaceutical division updating institutional investors on status of development portfolio and implementation of new strategy with focus on#external innovation,#cell &#gene,#partnering,#oncology,#cardiology,#China at#JPM2020#CollaborateToCurepic.twitter.com/XMgWgcnSVE
-
“At
#Bayer, we are very creative and flexible in our collaborations including#openinnovation with the goal of best serving the needs of today’s entrepreneurs” said Chris Haskell at#RESI#JPMorgan2020#JPM20@BayerPharma@BayerUS#JPM2020#CollaborateToCurepic.twitter.com/7aUfUemWCC
-
@realmikefox - acting icon and a leading figure in the fight against#Parkinsons, gave an inspiring keynote at Bayer’s exclusive#JPM20 reception at@SFMOMA. An enlightening example for the power of#collaboration.#CollborateToCure#JPM2020pic.twitter.com/9kSJ76sweb
-
“
#Bayer has been in China for 138 years. We have long standing relationships, and are the number three multinational there. We have tremendous capabilities to help bring assets to the market in#China,” said@MDDBacker at#JPM2020#JPM20@BayerUS#CollaborateToCure@JohnCendptspic.twitter.com/JCFf4oYz1m
-
„If we are serious about providing treatments for some of the most debilitating
#diseases, the pharma industry needs to acknowledge that harnessing targets developed outside of the organization could be more valuable than those developed internally“,@StefanOelrich at#JPM20pic.twitter.com/YlXCherpBh
-
Live from
#JPM20:@StefanOelrich, President of#Bayer’s Pharmaceuticals division, discusses deal making in the life sciences industry and shares insights of Bayer’s new era collaboration approach at the EY Life Sciences breakfast assembly.#CollaborateToCure#JPM2020@EYnewspic.twitter.com/2UVCS6B5KO
-
“We need to make sure that we can partner with the best and the brightest in the industry to ensure we capitalize on the right innovation that can translate into a product which will make an impact on patients”, said
@MDDBacker at#EASTWESTCEO@LeadingBiotech#JPM2020#JPM20pic.twitter.com/BiVI37Q85Q
-
Proud to see how
#Bayer#China President Wei Jiang and his team@BayerPharma support#patients in China through innovative medicines at the CHINA FOCUS@SAN FRANCISCO conference.#JPM20#JPM2020pic.twitter.com/2HgGYugIWR
-
We’re kicking off our presence at
#JPM20 and are pleased to announce that our Head of#BusinessDevelopment &#Licensing,@MDDBacker, will be participating in@LeadingBiotech’s#EastWestCEO Fireside Chat today at 2:45 p.m.PST.#CollaborateToCure#JPM2020 http://bit.ly/37IDYJf pic.twitter.com/AjpKslEyIY
-
Hear from us at
#JPM20! Bayer executives, including@stefanoelrich &@MDDBacker will share their views on a number of satellite events. Learn about Bayer's unique approach to#dealmaking & the value#Bayer brings to both partners and patients.#CollaborateToCure#JPM2020pic.twitter.com/mkAEserChS
-
10 days until 2020!
#DYK just 10 minutes of brisk walking every day is effective for lowering#bloodpressure ?#CardiovascularCountdownpic.twitter.com/NDyFU76OmF
-
15 days until 2020!
#DYK within 15 years after quitting smoking, your risk of#coronary artery#disease (#CAD) can return to that of a nonsmoker?#CardiovascularCountdownpic.twitter.com/J17kI4Daun
-
#NEWS: Congratulations to our Head of Business Development & Licensing@MDDBacker on joining@ArrowheadPharma’s Board of Directors to help guide in their patient-focused endeavor: https://bit.ly/2slkwD8 pic.twitter.com/iYVOr1AiQK
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.